Sina Score as a New Machine Learning-Derived Online Prediction Model of Mortality for Cirrhotic Patients Awaiting

Seyed Mohammad Kazem Hosseini-Asl1, Seyed Jalil Masoumi2,3,4, Ghazaleh Rashidizadeh5

  • 1Department of Internal Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz 7193613311, Iran.

PubMed

Insights

A new machine learning model, the Sina score, accurately predicts three-month mortality in cirrhosis patients awaiting liver transplants. This novel approach shows similar precision to the existing Model for End-Stage Liver Disease (MELD) score.

Area of Science:

  • Hepatology
  • Medical Informatics
  • Prognostic Modeling

Background:

  • Cirrhosis contributes significantly to global mortality.
  • Current scoring systems present challenges in organ allocation for end-stage liver disease.
  • Anthropometric indices are crucial for predicting cirrhosis patient prognosis.

Purpose of the Study:

  • To evaluate a machine learning approach for predicting three-month mortality in cirrhotic patients awaiting liver transplantation.
  • To develop and validate a novel scoring system using clinical and anthropometric data.
  • To compare the performance of the new model against the Model for End-Stage Liver Disease (MELD) score.

Main Methods:

  • Collected clinical and anthropometric data from 64 cirrhotic patients.
  • Employed a LASSO logistic regression model for developing the "Sina score".
  • Assessed hand grip, skeletal muscle mass index, mean arterial pressure, serum sodium, and total bilirubin.

Main Results:

  • The Sina score demonstrated precise prediction of three-month mortality (AUC = 0.753, p = 0.005).
  • The Model for End-Stage Liver Disease (MELD) score showed less precision (AUC = 0.607, p = 0.238).
  • The Sina score's prognostic capability was comparable to the MELD score.

Conclusions:

  • The Sina score is a precise prognostic tool for predicting three-month mortality in cirrhotic patients.
  • Its precision is on par with the MELD score.
  • The Sina score can be recommended for predicting three-month mortality in liver transplant candidates.